Mydriatic response to different concentrations of intracameral phenylephrine in humans.
PURPOSE: To assess the mydriatic response to concentrations of intracamerally injected phenylephrine from 0.15 mg/mL to 30.00 mg/mL (0.015% to 3.000%) in human eyes. SETTING: Department of Clinical Science/Ophthalmology, Umeå University Hospital, Umeå, Sweden. DESIGN: Comparative case series. METHODS: This prospective randomized double-masked study comprised patients scheduled for phacoemulsification cataract surgery. At the beginning of the procedure, patients received an intracameral injection of 0.15 mL of phenylephrine 0.15, 0.5, 1.5, 5.0, 15.0, or 30.0 mg/mL. To assess the mydriatic response, the pupil size was registered over 60 seconds using digital video recording. Then, the surgery was performed in the standard manner. RESULTS: The study evaluated 42 patients. The mydriatic response was almost identical at the 4 lower phenylephrine concentrations (0.15 to 5.00 mg/mL; 0.015% to 0.500%), with final pupil sizes of approximately 4.3 mm. The 2 higher concentrations gave significantly larger pupils as follows: mean 5.80 mm ± 0.79 (SD) for 15.0 mg/mL (1.5%) and 6.65 mm ± 0.57 for 30.0 mg/mL (3.0%). CONCLUSIONS: Results show that phenylephrine injected intracamerally does not have a linear mydriatic dose-response relationship in humans. At very high concentrations, phenylephrine may bind to and stimulate receptors other than the α(1)-receptor, explaining this phenomenon.[1]References
- Mydriatic response to different concentrations of intracameral phenylephrine in humans. Behndig, A., Lundberg, B. J. Cataract. Refract. Surg (2010) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg